PRKN and neoplasm: Together, our data demonstrate that PARK2 depletion contributes to PI3K/AKT activation via inactivation of PTEN by S-nitrosylation and provide several lines of evidence supporting the concept that inhibition of this pathway is important for PARK2's function as a tumor suppressor.